The following is a collection of current COVID-19 vaccine resources pertaining to myasthenia gravis from external organizations. This article is intended to provide the reader with general, updated information. It is not meant to be used as a substitute for medical advice. Should you have questions about the vaccine regarding your personal health and care plan, please consult your physician and medical providers.
COVID-19 & Myasthenia Gravis Resource List
The following resources are in alphabetical order.
Last Updated on December 16th, 2020
Brain and Life Magazine
Managing Myasthenia Gravis During the COVID-19 Pandemic
Center for Disease Control & Prevention (CDC)
General Information/Landing Page for Vaccines
Conquer MG
Resource Page for MG & COVID-19
Food & Drug Administration (FDA)
FDA COVID-19 Vaccine News & Updates
George Washington University School of Medicine & Health Sciences
Myasthenia Gravis and the COVID-19 Epidemic: Things for you to know
Presentation by: Hana Axelrod, MD, MPH, Henry J. Kaminski, MD, & Helen Girma
International MG/COVID-19 Working Group
"...because most patients with MG are on immunosuppressive or immunomodulatory therapies and may also have respiratory muscle weakness, there is a theoretical concern that MG/LEMS patients may be at higher risk of contracting the infection or experiencing severe manifestations of COVID-19."
Muscular Dystrophy Association (MDA)
COVID-19 Recommendations for the Neuromuscular Community
Myasthenia Gravis Foundation of America (MGFA)
Official Statement on COVID-19 Vaccine for the MG Community
Myasthenia Gravis News
MDA Wants Neuromuscular Disease Patients to Have Early Access to COVID-19 Vaccine
We will continue to update this list as we gather more information regarding the COVID-19 vaccines and myasthenia gravis.